Methods of making and using 1-methyleffusol
OwnerChi-Ming Che, Kai Yip Loinventors
Life of this patent
Estimating the term…
Abstract
Methods of making 1-methyleffusol are described herein. The 1-methyleffusol compound, and pharmaceutical compositions thereof, can be used to stimulate bone forming activities in a subject in need thereof.
Claims20
A method of making 1,8-dimethyl-4-vinyl-9,10-dihydrophenanthrene-2,7-diol, the method comprising the steps of
- (i) refluxing 1-(bromomethyl)-3-methoxy-2-methylbenzene and triphenylphosphine in solution to afford a phosphonium bromide;
- (ii) refluxing the phosphonium bromide and 3-methoxy-2-methylbenzaldehyde in an alkaline solution to afford (Z)- and (E)-1,2-bis(3-methoxy-2-methylphenyl)ethene stereoisomers;
- (iii) hydrogenating the (Z)- and (E)-1,2-bis(3-methoxy-2-methylphenyl)ethene to afford 1,2-bis(3-methoxy-2-methylphenyl)ethane stereoisomers;
- (iv) brominating the 1,2-bis(3-methoxy-2-methylphenyl)ethane to afford 5-bromo-1-methoxy-3-(3-methoxy-2-methylphenethyl)-2-methylbenzene;
- (v) oxidatively coupling the 5-bromo-1-methoxy-3-(3-methoxy-2-methylphenethyl)-2-methylbenzene to afford 4-bromo-2,7-dimethoxy-1,8-dimethyl-9,10-dihydrophenanthrene;
- (vi) demethylating the 4-bromo-2,7-dimethoxy-1,8-dimethyl-9,10-dihydrophenanthrene to afford 4-bromo-1,8-dimethyl-9,10-dihydrophenanthrene-2,7-diol;
- (vii) subjecting the 4-bromo-1,8-dimethyl-9,10-dihydrophenanthrene-2,7-diol to a Suzuki-coupling reaction with a vinyl trifluoroborate salt and a palladium salt to afford 1,8-dimethyl-4-vinyl-9,10-dihydrophenanthrene-2,7-diol;
- and
- (viii) purifying the 1,8-dimethyl-4-vinyl-9,10-dihydrophenanthrene-2,7-diol.
A pharmaceutical composition comprising:
- 1,8-dimethyl-4-vinyl-9,10-dihydrophenanthrene-2,7-diol or a pharmaceutically acceptable salt thereof;
- and
- one or more pharmaceutically acceptable carriers;
- and
- optionally one or more pharmaceutically acceptable excipients.
The pharmaceutical composition of claim 15, wherein the 1,8-dimethyl-4-vinyl-9,10-dihydrophenanthrene-2,7-diol or pharmaceutically acceptable salt thereof is at a concentration ranging from about 1 μM to about 10 mM, from about 1 μM to about 5 mM, from about 10 M to about 1 mM, or from about 10 μM to about 500 μM of the pharmaceutical composition.
A method of stimulating bone formation comprising administering the pharmaceutical composition of claim 15 to a subject in need thereof.
Dependencies are inferred from the claim text.